The efficiency of SGLT-2 inhibitor and dietary habits changes

Not Applicable

Conditions: Endocrine, nutritional and metabolic diseases

Registration Number: KCT0007619

Lead Sponsor: Kangbuk Samsung Medical Center

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 46

Inclusion Criteria

? Type 2 diabetes
? Between 19 and 70 years of age
? HbA1c >7.0%
? Patients without stable drug treatment or drug treatment history for more than 3 months.
? Subjects who have understood the contents of the clinical trial and voluntarily consented in writing
? Can write a diary well and agree to it

Exclusion Criteria

?Patients with a history of prescribing SGLT-2 inhibitors within 3 months
?Patients with a history of taking an appetite suppressant or GLP-1 agonist within 3 months
?Anemia (hemoglobin outside the normal range)
?People with a form of gastrointestinal disease that can affect appetite changes
?Liver disease (Alanine Aminotransferase, ALAT) and/or serum aspartaaminotransferase (ASAT) > 2 times normal) or history of liver disease
?Renal disease eGFR by MDRD equation less than 45 mL/min/1.73 m2
?Anorexia, bulimia, or bulimia
?When the investigator determines that physical or psychological circumstances may prevent participation in the trial

Study & Design

Study Type: Interventional Study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compare and evaluate changes in app-based dietary habits (total intake calories, frequency of hunger, frequency of food intake, and changes in dietary patterns) between groups with and without appropriate blood glucose changes after the addition of new diabetes medication

Secondary Outcome Measures

Name	Time	Method
Comparison and assessment of changes in app-based dietary habits (total intake calories, frequency of hunger, frequency of food intake, etc.) and changes in dietary intake (visual analogue scale) according to weight changes after the addition of new diabetes medication;Comparison of changes in nutritional composition (carbohydrate, fat, protein) between groups with appropriate blood sugar changes and those with no appropriate blood sugar changes after the addition of new diabetes medication